首页|AST/ALT、白蛋白与肝癌患者病理特征及TACE治疗预后的关系

AST/ALT、白蛋白与肝癌患者病理特征及TACE治疗预后的关系

扫码查看
目的 探究谷草转氨酶(AST)/谷丙转氨酶(ALT)、白蛋白与肝癌患者病理特征及经动脉化疗栓塞(TACE)治疗预后的关系.方法 选取2018年8月至2022年8月于临沂市肿瘤医院行TACE治疗的肝癌患者168例,据术后1年生存情况,将患者分为预后不良组27例和预后良好组141例,比较不同病理特征患者术前AST/ALT、白蛋白水平,比较不同预后TACE术后肝癌患者病理特征,比较不同预后TACE术后肝癌患者AST/ALT、白蛋白水平,采用ROC曲线分析其对肝癌患者TACE治疗预后的预测价值,采用Logistics二元回归方程分析AST/ALT、白蛋白对肝癌TACE治疗患者预后的影响作用.结果 年龄≥60岁、Child-Pugh B级、HbsAg阳性、肿瘤直径>5 cm、肿瘤多发、肿瘤分期更高、肿瘤低分化肝癌患者术前AST/ALT更高,术前白蛋白水平更低,差异均有统计学意义(P<0.05);两组年龄、HbsAg情况、肿瘤直径、肿瘤数量、肿瘤分期、分化程度比较差异均有统计学意义(P<0.05);预后良好组术前、术后AST/ALT低于预后不良组,术前、术后白蛋白水平高于预后不良组,差异有统计学意义(P<0.05);ROC结果显示,术前、术后的AST/ALT、白蛋白预测肝癌患者TACE治疗预后的AUC分别为0.887、0.787、0.854、0.580,联合预测的AUC为0.914(P<0.05);Logistic回归分析结果显示,年龄≥60岁、肿瘤直径>5 cm、肿瘤多发、肿瘤分期为Ⅲa期、肿瘤低分化、术前AST/ALT>1.82、术前白蛋白<33.21 g/L、术后AST/ALT>1.83、术后白蛋白<43.96 g/L均为肝癌患者TACE治疗预后不良的影响因素(P<0.05).结论 AST/ALT、白蛋白水平在不同病理特征肝癌患者中具有差异性,具有预测TACE治疗预后的作用.
Relationship of AST/ALT and albumin with pathological features and prognosis of TACE in patients with liver cancer
Objective To explore the relationship of aspartate aminotransferase(AST)/alanine aminotransferase(ALT)and albumin with pathological features and prognosis of transarterial chemoemboliza-tion(TACE)in patients with liver cancer.Methods 168 patients with liver cancer who received TACE treat-ment at Linyi Cancer Hospital from August 2018 to August 2022 were selected.Based on their survival status one year after surgery,the patients were divided into two groups:those with a good prognosis(27 cases)and those with a poor prognosis(141 cases).The study aimed to compare the differences in AST/ALT levels and albumin levels among patients who underwent TACE with different pathological features.To compare the path-ological characteristics,AST/ALT levels,and albumin levels of patients with hepatocellular carcinoma after TACE with different prognoses.ROC curve analysis was used to determine the predictive value of the above in-dicators on the prognosis of TACE in patients with liver cancer.Logistic binary regression equations were ap-plied to analyze the influence of AST/ALT and albumin on the prognosis of patients with liver cancer undergo-ing TACE.Results The preoperative AST/ALT levels were higher,while the preoperative albumin levels were lower among patients aged≥60 years old,with Child-Pugh grade B,positive HbsAg,tumor diameter>5 cm,multiple tumors,high tumor stage,and low tumor differentiation(P<0.05).There were statistically sig-nificant differences in age,HbsAg status,tumor diameter,quantity,staging,and differentiation degree be-tween the two groups(P<0.05).The preoperative and postoperative AST/ALT in good prognosis group were lower while the preoperative and postoperative albumin levels were higher than those levels in the poor progno-sis group(P<0.05).ROC results showed that the AUCs of preoperative and postoperative AST/ALT and albu-min independently in predicting the prognosis of TACE in patients with liver cancer were 0.887,0.787,0.854 and 0.580 respectively,and the AUC of combined prediction was 0.914(P<0.05).Logistic regression analysis showed that age≥60 years old,tumor diameter>5 cm,multiple tumors,tumor staging,low tumor differentia-tion,preoperative AST/ALT>1.82,preoperative albumin<33.21 g/L,postoperative AST/ALT>1.83,postop-erative albumin<43.96 g/L were all influencing factors affecting the poor prognosis of TACE in patients with liver cancer(P<0.05).Conclusion AST/ALT and albumin levels vary among liver cancer patients with dif-ferent pathological features,and they can predict the prognosis of TACE treatment.

Liver cancerTransarterial chemoembolizationAspartate aminotransferase/alanine aminotransferaseAlbumin

张超、柏祥云、薛凤华

展开 >

临沂市肿瘤医院介入科,山东,临沂 276000

临沂市肿瘤医院胸外科,山东,临沂 276000

肝癌 经动脉化疗栓塞 谷丙转氨酶/谷草转氨酶 白蛋白

山东省临沂市科技发展计划

202120025

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(5)
  • 7